Mammography

The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.

Latest News

AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer

March 18th 2025

While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.

Multicenter Mammography Study Shows Greater Than 10 Percent Increase in Breast Cancer Detection with Adjunctive AI
Multicenter Mammography Study Shows Greater Than 10 Percent Increase in Breast Cancer Detection with Adjunctive AI

March 10th 2025

ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography

February 28th 2025

Study Reveals Disparities in Use of Follow-Up Diagnostic Services After Abnormal Mammography Findings
Study Reveals Disparities in Use of Follow-Up Diagnostic Services After Abnormal Mammography Findings

February 18th 2025

How Does Hormonal Regulation Impact Background Parenchymal Enhancement on Contrast-Enhanced Mammography?
How Does Hormonal Regulation Impact Background Parenchymal Enhancement on Contrast-Enhanced Mammography?

February 12th 2025

Video Interviews
Latest CME Events & Activities

Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment

April 4, 2025 | New York, NY & Virtual

Register Now!

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

View More

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Register Now!

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

View More

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 12-14, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

43rd Annual Miami Breast Cancer Conference®

March 5-8, 2026

Register Now!

19th Annual New York GU Cancers Congress™

March 13-14, 2026

Register Now!

Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies

View More

Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice

View More

More News

© 2025 MJH Life Sciences

All rights reserved.